Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

Heather J. Chalfin(Johns Hopkins University), David J. McConkey(Johns Hopkins University), Michael H. Johnson(Johns Hopkins University), Megan Fong(Johns Hopkins University), Liang Dong(Chinese PLA General Hospital), Michael A. Gorin(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Andrés Matoso(Johns Hopkins University), Kenneth J. Pienta(Johns Hopkins University), Stephanie Glavaris(Johns Hopkins University), Max Kates(Duke Medical Center), Noah M. Hahn(Johns Hopkins University)
European Urology Oncology
September 26, 2019
10.1016/j.euo.2019.08.004
Cited by 43

Related Papers

Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Comprehensive molecular characterization of urothelial bladder carcinoma
|Nature|2014|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
|Cell|2017|2.5k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k